Anton Cruces-Sande

Dr. Anton Cruces-Sande

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2017 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
ACAnton Cruces-Sande
Anton Cruces-Sande
EMEstefanía Méndez‐Álvarez
Estefanía Méndez‐Álvarez
RSRamón Soto-Otero
Ramón Soto-Otero

23 June 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NVNestor Vazquez-Agra
Nestor Vazquez-Agra
ACAnton Cruces-Sande
Anton Cruces-Sande
SBSofia Barbosa-Gouveia
Sofia Barbosa-Gouveia
JLJose-Enrique Lopez-Paz
Jose-Enrique Lopez-Paz
MCMiguel Camafort
Miguel Camafort
AHAlvaro Hermida-Ameijeiras
Alvaro Hermida-Ameijeiras
High lipoprotein(a) (Lp(a)) levels are associated with an increased risk of arterial hypertension (AHT) and atherosclerotic cardiovascular disease. However, little is known about the detailed profile of AHT based on Lp(a) levels. This observational study focused on elucidating the relationship between Lp(a) concentrations and specific indices obtained from 24-h ambulatory blood pressure (BP) monitoring in hypertensive patients over 18 years of age. We gathered and analyzed data on BP indices along with demographic, epidemiological, clinical, and laboratory variables from 227 hypertensive patients, median age 56 years, including 127 women (56%). After comparing hypertensive patients with Lp(a) levels above and below 125 nmol/L, we found that a 10 mmHg increase in nocturnal systolic BP and all pulse pressure indices (24-h, daytime, and night-time) was associated with an increased risk of high Lp(a) levels by more than 20% and 40%, respectively. Similarly, each 10% increase in the area under the function over time of nocturnal diastolic BP dipping was associated with more than a 30% decrease in the odds of belonging to the elevated Lp(a) levels category. Additionally, Lp(a) levels above 125 nmol/L were associated with higher 24-h, daytime, and night-time systolic BP and pulse pressure load. The relationship between Lp(a) and AHT appears to extend beyond conventional BP measurements, which may be relevant given the prognostic implications of nocturnal BP and pulse pressure indices.

9 December 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
NVNestor Vazquez-Agra
Nestor Vazquez-Agra
ACAnton Cruces-Sande
Anton Cruces-Sande
EMEstefanía Méndez-Álvarez
Estefanía Méndez-Álvarez
RSRamón Soto-Otero
Ramón Soto-Otero
SCSergio Cinza-Sanjurjo
Sergio Cinza-Sanjurjo
Alvaro HermidaAlvaro Hermida
Alvaro Hermida
An impaired nocturnal decrease in diastolic blood pressure (DBP) increases the blood pressure (BP) load, which is a main factor in endothelial dysfunction, atherosclerosis, and arterial stiffness. We aimed to quantify some markers of oxidative stress in hypertensive patients, to compare their levels between individuals with dipper and non-dipper DBP profiles, and to assess their correlation with the nocturnal DBP (nDBP) dipping. It was an observational study that included patients older than 18 years with a diagnosis of essential hypertension who consented to participate. The collected variables were some indices of 24-h ambulatory blood pressure monitoring, demographic, epidemiological, clinical, and laboratory variables. Plasma thiobarbituric acid reactive substances (TBARS) and reduced thiols, together with serum vitamin E, vitamin A, copper (Cu), and zinc (Zn) levels were assessed as oxidative stress markers. We recruited 248 patients with a median age of 56 years (56% women). The percentage of nDBP dipping showed a weak positive correlation with reduced thiol, vitamin E, and vitamin A levels; and a weak negative correlation with Cu levels. We also found a negative correlation between nDBP dipping and the TBARS/Thiol, TBARS/Vitamin E, and TBARS/Vitamin A ratios. After multivariate analysis, we found that increased TBARS/Thiol ratio and serum Cu levels were associated with a higher risk of a non-dipper DBP profile. As in other situations of increased cardiovascular risk, an impaired nDBP decrease may coincide with abnormalities in redox status.

6 October 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NVNestor Vazquez-Agra
Nestor Vazquez-Agra
AMAna-Teresa Marques-Afonso
Ana-Teresa Marques-Afonso
ACAnton Cruces-Sande
Anton Cruces-Sande
INIgnacio Novo-Veleiro
Ignacio Novo-Veleiro
APAntonio Pose-Reino
Antonio Pose-Reino
AHAlvaro Hermida-Ameijeiras
Alvaro Hermida-Ameijeiras
We aimed to evaluate the correlation of plasma levels of thiobarbituric acid reactive substances (TBARS) and reduced thiols with morbidity, mortality and immune response during and after SARS-CoV-2 infection. This was an observational study that included inpatients with SARS-CoV-2 infection older than 65 years. The individuals were followed up to the twelfth month post-discharge. Plasma levels of TBARS and reduced thiols were quantified as a measure of lipid and protein oxidation, respectively. Fatal and non-fatal events were evaluated during admission and at the third, sixth and twelfth month post-discharge. Differences in oxidative stress markers between the groups of interest, time to a negative RT-qPCR and time to significant anti-SARS-CoV-2 IgM titers were assessed. We included 61 patients (57% women) with a mean age of 83 years old. After multivariate analysis, we found differences in TBARS and reduced thiol levels between the comparison groups in fatal and non-fatal events during hospital admission. TBARS levels were also correlated with fatal events at the 6th and 12th months post-discharge. One year after hospital discharge, other predictors rather than oxidative stress markers were relevant in the models. The median time to reach significant anti-SARS-CoV-2 IgM titers was lower in patients with low levels of reduced thiols. Assessment of some parameters related to oxidative stress may help identify groups of patients with a higher risk of morbidity, mortality and delayed immune response during and after SARS-CoV-2 infection.

18 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Alvaro HermidaAlvaro Hermida
Alvaro Hermida
NVNestor Vazquez-Agra
Nestor Vazquez-Agra
ACAnton Cruces-Sande
Anton Cruces-Sande
EMEstefanía Méndez-Álvarez
Estefanía Méndez-Álvarez
RSRamón Soto-Otero
Ramón Soto-Otero
AGArturo Gonzalez-Quintela
Arturo Gonzalez-Quintela
To date, no model has jointly encompassed clinical, inflammatory, and redox markers with the risk of a non-dipper blood pressure (BP) profile. We aimed to evaluate the correlation between these features and the main twenty-four-hour ambulatory blood pressure monitoring (24-h ABPM) indices, as well as to establish a multivariate model including inflammatory, redox, and clinical markers for the prediction of a non-dipper BP profile. This was an observational study that included hypertensive patients older than 18 years. We enrolled 247 hypertensive patients (56% women) with a median age of 56 years. The results showed that higher levels of fibrinogen, tissue polypeptide-specific antigen, beta-2-microglobulin, thiobarbituric acid reactive substances, and copper/zinc ratio were associated with a higher risk of a non-dipper BP profile. Nocturnal systolic BP dipping showed a negative correlation with beta-globulin, beta-2-microglobulin, and gamma-globulin levels, whereas nocturnal diastolic BP dipping was positively correlated with alpha-2-globulin levels, and negatively correlated with gamma-globulin and copper levels. We found a correlation between nocturnal pulse pressure and beta-2-microglobulin and vitamin E levels, whereas the day-to-night pulse pressure gradient was correlated with zinc levels. Twenty-four-hour ABPM indices could exhibit singular inflammatory and redox patterns with implications that are still poorly understood. Some inflammatory and redox markers could be associated with the risk of a non-dipper BP profile.

25 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NVNestor Vazquez-Agra
Nestor Vazquez-Agra
AMAna-Teresa Marques-Afonso
Ana-Teresa Marques-Afonso
ACAnton Cruces-Sande
Anton Cruces-Sande
INIgnacio Novo-Veleiro
Ignacio Novo-Veleiro
JLJose-Enrique Lopez-Paz
Jose-Enrique Lopez-Paz
Alvaro HermidaAlvaro Hermida
Alvaro Hermida
We aimed to explore the influence that the circadian blood pressure (BP) profile could exert on the correlation between some inflammatory markers and hypertension-mediated organ damage (HMOD). This was a cross-sectional study that included patients with primary arterial hypertension older than 18 years old. We included some parameters of 24 h ambulatory blood pressure monitoring collection and several inflammatory markers, as follows: platelet count (PTC), erythrocyte sedimentation rate (ESR), ultrasensitive C-reactive-protein, ferritin, fibrinogen, and uric acid. Myocardial hypertrophy, albuminuria, carotid intima-media thicknesses and ankle brachial index were assessed as HMOD presentations. Individuals were divided into two groups: patients with and without HMOD. We included 522 patients (47% women, mean age of 54 years). Multivariate logistic regression analysis showed that male patients older than 50 years old with uric acid levels above 7 mg/dL, ESR higher than 20 mm/h, fibrinogen greater than 320 mg/dL and PTC lower than 275 × 103/µL were associated with HMOD (p < 0.05). The circadian BP profile (dipper versus non-dipper pattern) did reach neither statistical significance nor influence the odds ratio of those inflammatory markers for HMOD. We found that differences in some inflammatory markers between patients with and without HMOD were not explained by a different circadian BP profile.